tiprankstipranks
CytoDyn CEO says leronlimab has ‘potential to be life-changing therapeutic’
PremiumThe FlyCytoDyn CEO says leronlimab has ‘potential to be life-changing therapeutic’
2M ago
CytoDyn engages CRO for Phase II inflammation trial
Premium
The Fly
CytoDyn engages CRO for Phase II inflammation trial
3M ago
CytoDyn completes FDA meeting on Phase II Study of leronlimab
Premium
The Fly
CytoDyn completes FDA meeting on Phase II Study of leronlimab
3M ago
CytoDyn to host business news update conference call
PremiumThe FlyCytoDyn to host business news update conference call
9M ago
CytoDyn to host business news update conference call
Premium
The Fly
CytoDyn to host business news update conference call
9M ago
CytoDyn to host business news update conference call
Premium
The Fly
CytoDyn to host business news update conference call
9M ago
CytoDyn appoints Jacob Lalezari as CEO, Michael Cohen as interim CFO
PremiumThe FlyCytoDyn appoints Jacob Lalezari as CEO, Michael Cohen as interim CFO
10M ago
CytoDyn appoints Jacob Lalezari as interim CEO
Premium
The Fly
CytoDyn appoints Jacob Lalezari as interim CEO
1y ago
CytoDyn to host update conference call
Premium
The Fly
CytoDyn to host update conference call
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100